Novel Affibody Molecules Specifically Bind to SARS-CoV-2 Spike Protein and Efficiently Neutralize Delta and Omicron Variants

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has been an unprecedented public health disaster in human history, and its spike (S) protein is the major target for vaccines and antiviral drug development. Although widespread vaccination has been well established, the viral...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Wangqi, Jiang, Peipei, Li, Qingfeng, Wen, He, Zheng, Maolin, Zhang, Jing, Guo, Yanru, Yang, Jia, Feng, Weixu, Ye, Sisi, Kamara, Saidu, Jiang, Pengfei, Chen, Jun, Li, Wenshu, Zhu, Shanli, Zhang, Lifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927262/
https://www.ncbi.nlm.nih.gov/pubmed/36511681
http://dx.doi.org/10.1128/spectrum.03562-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927262/
https://www.ncbi.nlm.nih.gov/pubmed/36511681
http://dx.doi.org/10.1128/spectrum.03562-22

Ejemplares similares